Personalized prescription of ACEI/ARBs for hypertensive COVID-19 patients

The COVID-19 pandemic has prompted an international effort to develop and repurpose medications and procedures to effectively combat the disease. Several groups have focused on the potential treatment utility of angiotensin-converting–enzyme inhibitors (ACEIs) and angiotensin-receptor blockers (ARBs...

Descripción completa

Detalles Bibliográficos
Autores principales: Bertsimas, Dimitris, Borenstein, Alison, Mingardi, Luca, Nohadani, Omid, Orfanoudaki, Agni, Stellato, Bartolomeo, Wiberg, Holly, Sarin, Pankaj, Varelmann, Dirk J., Estrada, Vicente, Macaya, Carlos, Gil, Iván J. Núñez
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7958102/
https://www.ncbi.nlm.nih.gov/pubmed/33721153
http://dx.doi.org/10.1007/s10729-021-09545-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7958102/
https://www.ncbi.nlm.nih.gov/pubmed/33721153
http://dx.doi.org/10.1007/s10729-021-09545-5

Ejemplares similares